Keywords: astellas, drops, pursuit, cv, thera, after, white

Astellas drops pursuit of CV Thera after "white knight" Gilead offers $1.4B

Article | 23 March 2009

Print This

Japanese drug major Astellas Pharma, which has been pursuing USA-based CV Therapeutics since last year, will not persist with its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in